Atea Pharmaceuticals Inc

NASDAQ:AVIR   12:36:13 PM EDT
24.86
+0.51 (+2.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.06B
Current PE86.59
Forward PE 28.91
2yr Forward PE 2.06
See more stats
Estimates Current Quarter
Revenue$58 Million
Adjusted EPS$0.00
See more estimates
10-Day MA$24.69
50-Day MA$23.16
200-Day MAN/A
See more pivots

Atea Pharmaceuticals Inc Stock, NASDAQ:AVIR

125 Summer Street, Boston, Massachusetts 02110
United States of America
Phone: +1.857.284.8891
Number of Employees: 39

Description

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.